KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Receivables - Other (2018 - 2025)

Historic Receivables - Other for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $12.3 million.

  • Twist Bioscience's Receivables - Other rose 56951.55% to $12.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.3 million, marking a year-over-year increase of 56951.55%. This contributed to the annual value of $3.9 million for FY2025, which is 8990.65% up from last year.
  • Latest data reveals that Twist Bioscience reported Receivables - Other of $12.3 million as of Q4 2025, which was up 56951.55% from $3.9 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Receivables - Other registered a high of $12.3 million during Q4 2025, and its lowest value of $800000.0 during Q1 2021.
  • Moreover, its 5-year median value for Receivables - Other was $3.1 million (2022), whereas its average is $3.9 million.
  • As far as peak fluctuations go, Twist Bioscience's Receivables - Other soared by 69450.0% in 2022, and later tumbled by 6015.38% in 2025.
  • Twist Bioscience's Receivables - Other (Quarter) stood at $5.8 million in 2021, then dropped by 9.94% to $5.3 million in 2022, then plummeted by 52.42% to $2.5 million in 2023, then decreased by 26.52% to $1.8 million in 2024, then surged by 569.52% to $12.3 million in 2025.
  • Its Receivables - Other was $12.3 million in Q4 2025, compared to $3.9 million in Q3 2025 and $1.0 million in Q2 2025.